Factors that modulate the psychomotor activating effects of amphetamine and cocaine, such as environmental novelty and dose, also regulate the ability of these drugs to induce c-fos mRNA expression in the subthalamic nucleus (STN). We hypothesized therefore that engagement of the STN may be important for stimulant-induced psychomotor activation. To further test this hypothesis we examined whether repeated treatment with cocaine, which enhances its psychomotor activating effects (i.e. produces behavioural sensitization), also enhances its ability to induce c-fos expression in the STN. In addition, given that STN activity is thought to be in¯uenced by preproenkephalin mRNA-containing (ENK) neurons in the caudate±putamen, we also examined whether repeated cocaine treatment alters c-fos expression in ENK cells. We report that: (i) cocaine pretreatment enhances the ability of a cocaine challenge to induce cfos mRNA expression in the STN, and this effect is most robust at challenge doses where behavioural sensitization is observed; (ii) the ability of cocaine to induce c-fos in the STN is independent of the ability of cocaine to engage ENK cells. These results support the idea that the STN is involved in stimulant-induced psychomotor activation and sensitization, but suggest that stimulant-induced engagement of the STN is not dependent on ENK cells in the caudate±putamen. These ®ndings may have implications concerning the neurobiological mechanisms underlying the behavioural effects of psychostimulant drugs.
Introduction
Over the past several decades much research has sought to identify the neural systems that mediate the behavioural effects of psychostimulant drugs, such as amphetamine and cocaine. It is now clear that many of their behavioural effects are due in large part to their ability to increase dopamine neurotransmission in the nucleus accumbens and caudate± putamen (CPu). On the other hand, very little is known about the importance of striatofugal targets. One such structure, the subthalamic nucleus (STN), is a principal component of the so-called`indirect pathway', a pathway which arises from enkephalin-containing cells in the CPu (ENK cells) (Albin et al., 1989) .
We have recently found that factors which in¯uence the ability of psychostimulants to produce psychomotor activation, such as environmental context and dose, also modulate their ability to induce c-fos mRNA expression in the STN. Speci®cally, low to moderate doses of amphetamine or cocaine given in a novel test environment induce more robust psychomotor activation and c-fos expression in the STN than when these doses are given in the home cage (Uslaner et al., 2001b; Ostrander et al., 2003; Uslaner et al., 2003) . Higher doses of amphetamine, which produce robust psychomotor activation when given in either the home cage or a novel environment (Browman et al., 1998) , induce robust c-fos expression in the STN independent of environmental context (Uslaner et al., 2003) . Therefore, we hypothesized that the ability of stimulant drugs to engage the STN may be important for their ability to produce psychomotor activation.
To further test this hypothesis we examined whether repeated treatment with cocaine (7 days with 15 mg/kg/day), which enhances its ability to produce psychomotor activation (i.e. behavioural sensitization), would also enhance its ability to induce c-fos expression in the STN. In addition, in order to examine whether ENK cells in the CPu (and presumably the indirect pathway) are involved in the ability of cocaine to engage the STN, we characterized the ability of cocaine pretreatment to modulate cocaine-induced c-fos expression in ENK cells in the CPu, using dual in situ hybridization histochemistry.
Testing environment All rats were treated in clear rectangular tubs (22 Â 45 Â 23 cm), each of which contained a clear plastic insert in the centre of the cage (6.5 Â 23 Â 23 cm) forming a corridor through which rats could locomote. Three sets of infrared photocells were located along the length of the tub and were spaced %11.5 cm apart from one another. A break was counted each time a photo beam was interrupted.
Testing procedures
Each pretreatment day, rats were transported from their home cages, placed into the testing environment and left to habituate for 30 min. The habituation period was used to attenuate the development of a conditioned response (Crombag et al., 2001) . Following the habituation period, each rat received an i.p. injection of either saline or 15 mg/ kg of cocaine. Sixty minutes following the injection, the rats were returned to their home cages in the animal colony. All rats received saline or cocaine treatment for 7 consecutive days, after which they were left undisturbed in the animal colony room for a 3-week withdrawal period. Following the withdrawal period, saline-and cocainepretreated rats were brought back to the test environment, habituated for 30 min and then given a challenge injection of saline or 7.5, 15, or 30 mg/kg of cocaine (n 8±11/group).
Fifty minutes after the challenge injection each rat was decapitated and the brain was removed and immediately frozen in isopentane (À40 to À50 8C). The 50-min timepoint was chosen because it was used in previous studies and because it coincides with maximal c-fos mRNA expression (Badiani et al., 1998 (Badiani et al., , 1999 Uslaner et al., 2001a; Uslaner et al., 2001b) . The brains were stored in a À70 8C freezer until they were sectioned. A cryostat was used to cut 10-mm-thick coronal sections at the level of the CPu and STN (% 0.8 and 4 mm posterior to bregma, respectively). The sections were thaw-mounted onto slides coated with polylysine and stored at À70 8C until processing for in situ hybridization.
In situ hybridization and quantification of mRNA All in situ hybridization methods were as described previously (Uslaner et al., 2001b) except that dual in situ hybridization was performed using 35 S-UTP-and 35 S-CTP-labelled riboprobes for c-fos mRNA (680-mer; courtesy of Dr T. Curran), and digoxigenin±UTP-labelled riboprobes complimentary for preprotachykinin mRNA [substance P (SP)] or preproproenkephalin mRNA (567-mer and 693-mer, respectively; courtesy of Dr J. Douglass, Amgen, Thousand Oaks, CA, USA). The single in situ hybridization method was adapted from that described by Cullinan et al. (1995) and the double in situ hybridization method from that by Curran & Watson (1995) . Sections containing the STN were processed for single in situ hybridization using the riboprobe complementary to c-fos mRNA. Sections containing the CPu were processed for dual in situ hybridization using the riboprobe complementary to c-fos mRNA and preprotachykinin or preproenkephalin mRNA. Single-labelled sections were exposed to X-ray ®lm (Kodak Biomax, MR) for %3 days. Double-labelled sections were dipped in Ilford KD-5 emulsion (Polysciences) and stored at 4 8C (% 7 days). After development , the slides were dehydrated in graded alcohols and coverslipped with Permount.
Quantification
Single-labelled sections were quanti®ed as described previously (Badiani et al., 1998) . Brie¯y, brain images were captured with a Sony CCD camera from the X-ray ®lm, and semiquantitative analysis was performed on the digitized autoradiograms using National Institute of Health Image Software (NIH Image). Pixels were counted when the optical density values were at least 3.5 SD above background value (background obtained from corpus callosum; macro written by Dr S. Campeau, University of Colorado, Boulder). Thus, the data are represented as relative integrated optical density in arbitrary units, which re¯ects both signal intensity and the number of pixels above background divided by total area (Badiani et al., 1998; Day et al., 2001) . Adjacent sections were stained with Cresyl Violet to help with anatomical localization. Double-labelled tissue from the CPu was quanti®ed using a Leica microscope (Leitz DMR, Wetzler, Germany) at a total magni®cation of 200Â. Digoxigenin-labelled cells appeared as a purple precipitate in bright®eld conditions, and a cell was considered positive only when it was a much darker hue of purple than background (background obtained from corpus callosum).
35 S-labelled cells appeared as densely packed silver grains in dark®eld conditions, and a cell was considered positive only when the density of silver grains was clearly above background. The same criteria were used to analyse all slides, and the experimenter quantifying the tissue was blind to treatment conditions. We analysed a 500 Â 500-mm portion of the dorsomedial and dorsolateral CPu in each hemisphere. There were no differences in cell counts between these areas, so they were combined. We examined these regions within the CPu because in previous studies we found that cocaine-induced c-fos expression was greatest in this area of the caudal CPu (Uslaner et al., 2001a) .
Controls
To ensure that nonspeci®c binding was minimal, we performed control experiments on striatal tissue using sense strands for c-fos, preprotachykinin and preproenkephalin mRNA. There was no binding of the sense probes. Furthermore, we examined whether the preprotachykinin and preproenkephalin antisense probes labelled separate cells within the CPu by performing dual in situ hybridization using 35 S-UTP-and 35 S-CTP-labelled preprotachykinin and digoxigenin-UTP-labelled preproenkephalin. We examined the same regions of the CPu as in the rest of the study. There were very few cells that were positive for both preproenkephalin and preprotachykinin mRNA in the CPu [101 of 2154 ENK cells were also SP (4.7%); 101 out of 2284 SP cells were also ENK (4.4%)], con®rming previous reports that, based on mRNA expression, these two cell populations in the CPu are almost completely segregated (Gerfen et al., 1988) .
Statistical analysis
To investigate whether there was a difference in locomotor behaviour (beam breaks) during the pretreatment phase, a mixed two-way ANOVA was conducted (Dose, two levels; Day, seven levels).
The results from the challenge test were analysed by making two sets of comparisons. (i) To determine whether a particular treatment enhanced locomotor behaviour (number of beam breaks) or c-fos mRNA expression above baseline, data were normalized by subtracting the mean of the saline challenged groups from the value for each individual subject, and then a one-sample t-test was used to determine whether group means were signi®cantly different from zero. The cocaine-and saline-pretreated groups that received a saline challenge injection did not differ on any of the measurements examined, so they were combined. (ii) To determine whether cocaine-induced locomotor behaviour or c-fos mRNA expression varied as a function of pretreatment and/or dose, two-way ANOVAs (Pretreatment, two levels; Dose, four levels) were conducted, followed by Fisher's PLSD tests for pairwise comparisons. For all comparisons a < 0.05.
In addition, we examined the relationship between c-fos expression in the STN and locomotor behaviour on the day of the challenge by calculating correlation coef®cients, followed by Fisher's exact tests.
Results

Cocaine-induced psychomotor activity
The insert in the top panel of Fig. 1 shows the behavioural results from the pretreatment phase of the experiment. ANOVA revealed a signi®cant interaction between Day and Dose (F 6, 483 5.64, P < 0.0001), which resulted from the increasing behavioural response produced by cocaine across pretreatment days (i.e. sensitization).
The top panel of Fig. 1 shows the behavioural results from the challenge injection administered 3 weeks after the ®nal (7th) pretreatment injection. Saline-pretreated rats showed a signi®cantly greater locomotor response to an injection of 30 mg/kg of cocaine, relative to baseline (P < 0.04), but none of the other doses produced a signi®cant effect in saline-pretreated rats. In contrast, cocaine-pretreated rats that received either a 15 or 30 mg/kg cocaine challenge injection showed a signi®cantly greater locomotor response than baseline (P < 0.012). Furthermore, there was an interaction between Dose and Pretreatment (F 3,64 3.73, P < 0.017), which was because cocaine pretreatment produced a shift to the left in the dose±effect function for psychomotor activity. The effect of cocaine pretreatment was most pronounced and reached statistical signi®cance when a challenge dose of 15 mg/kg was given (P < 0.02). Figure 2 shows the time course of the behavioural response to the challenge injection.
Cocaine-induced c-fos expression in the STN
The bottom panel of Fig. 1 shows the dose±effect curve for cocaineinduced c-fos mRNA expression (integrated density) in the STN as a function of pretreatment condition. Animals pretreated with saline and given a 15 or 30 mg/kg cocaine challenge injection showed signi®-cantly enhanced levels of c-fos expression in the STN, compared to baseline (P < 0.026), but the effect of 7.5 mg/kg was not statistically signi®cant. In contrast, animals pretreated with cocaine and challenged with either 7.5, 15 or 30 mg/kg of cocaine all showed a signi®cant increase in c-fos expression in the STN, relative to baseline (P < 0.032). ANOVA revealed a signi®cant Dose Â Pretreatment interaction (F 3,64 2.94, P < 0.04). Thus, similar to the psychomotor activating response, cocaine pretreatment produced a shift to the left in the dose±effect function for cocaine-induced c-fos expression in the STN. This effect of cocaine pretreatment was most pronounced and reached statistical signi®cance when a challenge dose of 15 mg/kg of cocaine was given (P < 0.02), again similar to the effect of cocaine pretreatment on psychomotor activity (see above).
Given the similarity of the dose±effect functions for cocaineinduced c-fos expression in the STN and locomotor activity, correlations between these variables were examined. When all animals were included in the analysis and plotted individually, there was a signi®cant correlation between c-fos expression in the STN and the number of beam breaks (r 0.66, P < 0.0001; top panel of Fig. 3) . Importantly, the correlation was greatest for those treatments that produced robust cocaine-induced behavioural effects. Thus, correlations between beam breaks and c-fos induction in the STN was greatest for animals receiving 15 or 30 mg/kg of cocaine following cocaine pretreatment (r 0.592 and 0.627, respectively) or 30 mg/kg of cocaine following saline pretreatment (r 0.555; data not shown). When the correlation analysis was conducted on the group means for c-fos expression in the STN and psychomotor activity, the correlation between these two measures was even greater (r 0.89, P < 0.02; bottom panel of Fig. 3 ).
Cocaine-induced c-fos expression in the CPu
The top panel of Fig. 4 shows the number of c-fos cells in the CPu as a function of pretreatment condition and challenge dose. All doses of cocaine, irrespective of pretreatment, increased the number of c-fos cells in the CPu relative to baseline (P < 0.008). Higher doses of cocaine increased the number of c-fos cells in the CPu to a greater extent than lower doses (effect of Dose, F 3,65 36.452, P < 0.0001), but there was no effect of Pretreatment (F 1,65 2.74, P 0.1) and no Dose Â Pretreatment interaction (F 3,65 2.04, P 0.117).
The middle panel of Fig. 4 shows the number of SP cells that were also positive for c-fos (SP/c-fos) in the CPu as a function of treatment condition and challenge dose. Irrespective of pretreatment condition, all doses of cocaine increased the number of SP/c-fos cells (P < 0.03). Higher doses increased the number of SP/c-fos cells to a greater extent than lower doses (F 3,64 27.094, P < 0.0001), but there was no effect of Pretreatment (F 1,64 1.058, P 0.308) and no Dose Â Pretreatment interaction (F 3,64 1.39, P 0.253).
The bottom panel of Fig. 4 shows the number of ENK cells that were also c-fos (ENK/c-fos) in the CPu as a function of pretreatment condition and challenge dose. Other than the group pretreated with cocaine and given a 7.5-mg/kg challenge, all groups showed an increase in the number of ENK/c-fos cells relative to baseline. Higher doses increased the number of ENK/c-fos cells compared to lower doses (F 3,64 19.312, P < 0.0001), but there was no effect of Pretreatment (F 1,64 0.392, P 0.5337) and no Dose Â Pretreatment interaction (F 3,64 2.313, P 0.0844).
Discussion
We reported previously that conditions which enhance the ability of amphetamine and cocaine to produce psychomotor activation also increase their ability to induce c-fos expression in the STN (Uslaner et al., 2001b; Ostrander et al., 2003; Uslaner et al., 2003) . We hypothesized therefore that the ability of these drugs to engage the STN may be important for their ability to produce robust psychomotor activation. This hypothesis was tested here by employing a cocaine pretreatment regimen that enhances the ability of a cocaine challenge to produce psychomotor activation (i.e. behavioural sensitization). We predicted that pretreatment with cocaine would also enhance its ability to induce c-fos expression in the STN. It did. Furthermore, given that ENK cells in the CPu in¯uence the STN via the indirect pathway, we predicted that repeated treatment with cocaine would enhance its ability to induce c-fos expression in ENK cells. It did not. Each of these ®ndings will be discussed in turn.
The relationship between psychomotor activation and engagement of the STN The present ®ndings clearly support the idea that engaging the STN may be important for the psychomotor activating effects of stimulant drugs. First, similar to our ®ndings with a single injection of amphetamine (Uslaner et al., 2003) , cocaine produced a dose-dependent increase in c-fos mRNA expression in the STN that was accompanied by a dose-dependent increase in psychomotor activation. Second, cocaine pretreatment produced a shift to the left in the dose±effect function for cocaine-induced c-fos mRNA expression in the STN that was very similar to the shift in the dose±effect function for psychomotor activation. Pretreatment with cocaine enhanced the ability of the 15 mg/kg cocaine challenge to induce c-fos mRNA expression in the STN and to produce psychomotor activation, relative to pretreatment with saline. The 30 mg/kg challenge of cocaine induced robust c-fos expression in the STN and robust psychomotor activation, regardless of the animal's drug history. These results extend previous ®ndings from our laboratory demonstrating enhanced amphetamine-induced cfos mRNA expression in the STN as a function of prior drug experience (Ostrander et al., 2003) . Third, there was a positive correlation between cocaine-induced c-fos mRNA expression in the STN and psychomotor activation.
The role of the STN in stimulant-induced psychomotor activation has not received much attention until quite recently. There is, however, increasing evidence that it is involved. For example, it has been reported that acute injections of either methamphetamine or cocaine increases glucose utilization in the STN (Porrino et al., 1988; Pontieri et al., 1990) , and acute amphetamine administration increases c-fos expression and cell ®ring in the STN (Ishida et al., 1998; Olds et al., 1998 Olds et al., , 1999 . In addition, bilateral STN lesions attenuate the ability of a single acute administration of cocaine to induce psychomotor activation (Baunez et al., 2002) . Thus, the available literature, along with the results reported here, suggests that the STN plays an important role in mediating the psychomotor activating effects of stimulant drugs.
The mechanism(s) by which the STN in¯uences the ability of stimulant drugs to produce psychomotor activation is unknown. However, glutamatergic projections from the STN to the ventral tegmental area (VTA) and the substantia nigra pars compacta (SNc) may be involved (Kita & Kitai, 1987; Groenewegen & Berendse, 1990) . Stimulation of the STN enhances cell ®ring in midbrain dopamine neurons (Hammond et al., 1978; Smith & Grace, 1992) , presumably engaging mesolimbic and nigrostriatal circuitry and inducing dopamine release in the striatum (Bruet et al., 2001) . Indeed, glutamatergic agonists infused onto the STN induce Fos-immunoreactivity in the striatum and produce motor activation (Kearney & Albin, 2000) . Importantly then, glutamate and dopamine are known to be critical for stimulant-induced psychomotor activation. Systemically administered glutamate or dopamine antagonists (Maj et al., 1972; Schlechter & Butcher, 1972; Karler et al., 1989; Karler et al., 1990) , or lesions of dopamine projections to the striatum (Creese & Iversen, 1974; Kelly et al., 1975; Kelly & Iversen, 1976) , block the psychomotor activating effects of both amphetamine and cocaine. Thus, by engaging mesolimbic and nigrostriatal circuitry, and thereby enhancing dopamine release in the striatum, engagement of the STN may potentiate stimulant-induced psychomotor activation. Of course, STN projections to other brain regions thought to be involved in stimulant-induced psychomotor activation, such as the globus pallidus (Kita & Kitai, 1987; Groenewegen & Berendse, 1990 ) and the striatum (Kita & Kitai, 1987; Parent & Smith, 1987) , may also be important.
The relationship between stimulant-induced engagement of the STN and ENK cells in the CPu
Given that ENK cells are thought to in¯uence the STN via the indirect pathway (Albin et al., 1989) , we had hypothesized that engaging ENK cells in the CPu would be important for the ability of stimulant drugs to engage the STN. However, our current ®ndings suggest that the ability of psychostimulant drugs to engage the indirect pathway (at least as indicated by c-fos mRNA expression in ENK cells) is not necessary to induce c-fos in the STN. Pretreatment with cocaine enhanced the ability of a 15-mg/kg challenge of cocaine to induce c-fos in the STN, but had no effect on the ability of cocaine to engage ENK cells. Others have also reported that repeated treatment with stimulant drugs does not enhance their ability to induce c-fos or Fos-immunoreactivity in ENK cells (Jaber et al., 1995; Moratalla et al., 1996; Canales & Graybiel, 2000) . In addition, we have previously found that a high dose of amphetamine (10 mg/kg) induces robust c-fos mRNA expression in the STN but does not induce c-fos in very many ENK cells (Uslaner et al., 2003) . Moreover, lesions of the globus pallidus, which prevent ENK cells from in¯uencing the STN via the indirect pathway, do not dramatically alter the ability of amphetamine to increase neuronal ®ring in the STN (Olds et al., 1998) .
Of course, there are a variety of other inputs that could be important for the ability of cocaine to engage the STN. The SNc and VTA send dopaminergic projections to the STN (Campbell et al., 1985; Canteras et al., 1990; Hassani et al., 1997) , and dopamine agonists enhance neural activity (Mintz et al., 1986; Kreiss et al., 1996 Kreiss et al., , 1997 Ni et al., 2001 ) and c-fos expression in the STN (Ruskin & Marshall, 1995; Svenningsson & Le Moine, 2002) . In addition, the STN receives efferents from the prefrontal cortex (Canteras et al., 1990) , and cortical stimulation enhances neuronal ®ring (Maurice et al., 1998) and c-fos expression in the STN (Sgambato et al., 1997) . The involvement of these projections seems especially interesting, given the hypothesized involvement of these structures in the psychomotor activating effects of stimulant drugs (Eichler & Antelman, 1979; Robinson et al., 1985; Vezina & Stewart, 1990; Banks & Gratton, 1995; Pierce & Kalivas, 1997 ).
Conclusions
The current ®ndings suggest that the STN contributes to the psychomotor activating effects of cocaine. The ability of cocaine to induce cfos in the STN was enhanced by doses and treatment regimens that produced robust psychomotor activation. Furthermore, there was a signi®cant correlation between drug-induced c-fos expression in the STN and psychomotor activation. In addition, given that the expression of behavioural sensitization was observed at challenge doses where there was a signi®cant effect of pretreatment on cocaine-induced c-fos in the STN, the role of the STN in sensitization also merits consideration. In this regard, it is worth noting that stimulation of the STN produces LTP in dopamine-containing neurons in the SNc (Overton et al., 1999) , which may contribute to the sensitization process (Wolf, 1998) . Finally, given the possible relationship between sensitization and addiction (Robinson & Berridge, 1993) , future consideration of the role of the STN in the reinforcing effects of psychostimulants seems warranted. Indeed, the STN has also been implicated recently in the incentive motivational effects of cocaine (Baunez et al., 2002) .
